Items where Author is "Corradin, G."

2020

Geiger, K. M. and Guignard, D. and Yang, C. and Bikorimana , J.-P. and Correia, B. E. and Houard, S. and Mkindi, C. and Daubenberger, C. and Spertini, F. and Corradin, G.. (2020) Epitope mapping and fine specificity of human T and B cell responses for novel candidate blood-stage malaria vaccine P27A. Frontiers in Immunology, 11. p. 412.

2012

Kulangara, C. and Luedin, S. and Dietz, O. and Rusch, S. and Frank, G. and Mueller, D. and Moser, M. and Kajava, A. V. and Corradin, G. and Beck, H. P. and Felger, I.. (2012) Cell biological characterization of the malaria vaccine candidate trophozoite exported protein 1. PLoS ONE, Vol. 7, H. 10 , e46112.

2011

Olugbile, S. and Villard, V. and Bertholet, S. and Jafarshad, A. and Kulangara, C. and Roussilhon, C. and Frank, G. and Agak, G. W. and Felger, I. and Nebie, I. and Konate, K. and Kajava, A. V. and Schuck, P. and Druilhe, P. and Spertini, F. and Corradin, G.. (2011) Malaria vaccine candidate : design of a multivalent subunit alpha-helical coiled coil poly-epitope. Vaccine : the official journal of the International Society for Vaccines, 29 (40). pp. 7090-7099.

2009

Flueck, C. and Frank, G. and Smith, T. and Jafarshad, A. and Nebie, I. and Sirima, S. B. and Olugbile, S. and Alonso, P. and Tanner, M. and Druilhe, P. and Felger, I. and Corradin, G.. (2009) Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates. Vaccine : the official journal of the International Society for Vaccines, 27 (20). pp. 2653-2661.

Kulangara, C. and Kajava, A. V. and Corradin, G. and Felger, I.. (2009) Sequence conservation in Plasmodium falciparum á-helical coiled coil domains proposed for vaccine development. PLoS ONE, Vol. 4, H. 5 , e5419.

Bongfen, S. E. and Ntsama, P. M. and Offner, S. and Smith, T. and Felger, I. and Tanner, M. and Alonso, P. and Nebie, I. and Romero, J. F. and Silvie, O. and Torgler, R. and Corradin, G.. (2009) The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity. Vaccine : the official journal of the International Society for Vaccines, 27 (2). pp. 328-335.

Audran, R. and Lurati-Ruiz F., and Genton, B. and Blythman, H. E. and Ofori-Anyinam O., and Reymond, C. and Corradin, G. and Spertini, F.. (2009) The synthetic Plasmodium falciparum circumsporozoite peptide PfCS102 as a malaria vaccine candidate: a randomized controlled phase I trial. PLoS ONE, Vol. 4, H. 10 , e7304.

Olugbile, S. and Kulangara, C. and Bang, G. and Bertholet, S. and Suzarte, E. and Villard, V. and Frank, G. and Audran, R. and Razaname, A. and Nebie, I. and Awobusuyi, O. and Spertini, F. and Kajava, A. V. and Felger, I. and Druilhe, P. and Corradin, G.. (2009) Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c. Infection and Immunity, Vol. 77, H. 12. pp. 5701-5709.